SCHEMBL1882299

SCHEMBL1882299

COC(=O)c1cc(C)n(Cc2ccccc2)c1C(C)C

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.55
NOTUM Q6P988 1/20 0.55
MAPT P10636 2/20 0.48
THRB P10828 1/20 0.48
AR P10275 2/20 0.48
ALDH1A1 P00352 3/20 0.47
GAA P10253 2/20 0.47
PKM P14618 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
NPSR1 Q6W5P4 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KLKB1 P03952 2/20 0.46
KDM4E B2RXH2 1/20 0.46
KMT2A Q03164 1/20 0.46
S1PR3 Q99500 2/20 0.44
S1PR2 O95136 1/20 0.44
KLK1 P06870 2/20 0.43
MAPK8 P45983 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1877442 0.88 MAPT (0.49) TSHRNOTUMMAPTTHRBAR
SCHEMBL1877594 0.86 NOTUM (0.68) TSHRNOTUMMAPTTHRBALDH1A1
SCHEMBL1880402 0.85 MAPT (0.46) TSHRNOTUMMAPTTHRBAR
SCHEMBL1884213 0.85 MAPT (0.46) TSHRNOTUMMAPTTHRBAR
SCHEMBL1881339 0.81 MAPK8 (0.47) TSHRMAPTTHRBARALDH1A1
SCHEMBL1875614 0.80 GAA (0.60) TSHRNOTUMMAPTTHRBAR
SCHEMBL12672072 0.80 KMT2A (0.43) TSHRNOTUMMAPTTHRBAR
SCHEMBL1878254 0.80 MAPT (0.42) TSHRNOTUMMAPTTHRBAR
SCHEMBL12638304 0.78 TSHR (0.57) TSHRMAPTALDH1A1GAAPKM
SCHEMBL1878730 0.76 NOTUM (0.51) NOTUMMAPTTHRBARALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110105567-A1 Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity ALLERGAN, INC. (US) 2011-05-05 US disclosed
EP-2185506-A1 PYRROLE COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST OR ANTAGONIST BIOLOGICAL ACTIVITY Allergan, Inc. (US) 2010-05-19 EP disclosed
WO-2009026407-A1 PYRROLE COMPOUNDS HAVING SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST OR ANTAGONIST BIOLOGICAL ACTIVITY ALLERGAN, INC. (US) 2009-02-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105567-A1 Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity S1PR1, S1PR2, S1PR3 TSHR 296/4885NOTUM 822/4885MAPT 3241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.